DanCann Pharma A/S announced the successful QC analysis of its pre-validation batches. The Company has confirmed that all batches have been tested in accordance with European (German and Danish) standards, meeting the required specifications and further advancing the approval process. As part of its commitment to ensuring the higher standards of quality and compliance, DanCann Pharma conducted comprehensive testing of its pre-validation batches.

The testing process followed European (German and Danish) products. The results of the analysis have demonstrated that all pre-validation batches have successfully met the rigorous specifications set by European (German and Danish) standards. This achievement underscores DanCann Pharma's unwavering dedication to producing safe and effective therapeutic cannabinoids in line with the higher regulatory and industry requirements.